|
Market Closed -
Nasdaq
16:00:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 21.48 USD | -1.24% |
|
+4.27% | -18.30% |
| 09-22 | Oppenheimer Adjusts Price Target on Tyra Bioscience to $40 From $50, Keeps Outperform Rating | MT |
| 09-14 | Tyra Bioscience Shares Rise After Pricing $400 Million Offering | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TYRA BIOSCIENCES, INC. | Bio Therapeutic Drugs | -1.24% | +4.27% | -18.30% | +47.53% | -9.60% | 1.5B |  | | |
- Stock Market
- Stocks
- TYRA Stock
- Charts Tyra Biosciences, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
